戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 n with left ventricular flow reserve (FR) on dobutamine stress echocardiography.
2     Patients underwent exercise treadmill or dobutamine stress echocardiography.
3 etecting myocardial perfusion defects during dobutamine stress echocardiography.
4 p to 25 Hz in 114 of the 117 patients during dobutamine stress echocardiography.
5 is a feasible, well-tolerated alternative to dobutamine stress echocardiography.
6 xercise testing, symptom questionnaires, and dobutamine stress echocardiography.
7 nct to conventional visual interpretation of dobutamine stress echocardiography.
8  thallium stress testing and transesophageal dobutamine stress echocardiography.
9 rred in the 154 patients without ischemia on dobutamine stress echocardiography.
10 atropine in a large patient group undergoing dobutamine stress echocardiography.
11 isted coronary artery disease or ischemia at dobutamine stress echocardiography.
12  underwent standardized assessment including dobutamine stress echocardiography.
13 tic data exists on stress FR during low-dose dobutamine stress echocardiography.
14 yocardial work index variables during normal dobutamine stress echocardiography.
15  min) was significantly shorter than that of dobutamine stress echocardiography (15.1+/-3.9 min) (p =
16 ocardial perfusion (1,994 patients) and 5 on dobutamine stress echocardiography (446 patients).
17  In 181 consecutive patients undergoing both dobutamine stress echocardiography and coronary angiogra
18 ave been performed during low- and high-dose dobutamine stress echocardiography and have been applied
19 e postextrasystolic potentiation (PESP) with dobutamine stress echocardiography and multidetector com
20 jet velocity >2 and <4 m/s, at rest or after dobutamine stress echocardiography) and HFrEF (LVEF <50%
21  This study sought to document the safety of dobutamine stress echocardiography as it has evolved at
22 dministered in a double-blind fashion during dobutamine stress echocardiography, at separate visits a
23  One hundred eighty-three patients underwent dobutamine stress echocardiography before randomization.
24 armacological radionucleotide stress test or dobutamine stress echocardiography before transplant.
25 ine patients with class III/IV CHF underwent dobutamine stress echocardiography before treatment with
26 imaging was performed in 117 patients during dobutamine stress echocardiography by using an intraveno
27                             We conclude that dobutamine stress echocardiography can be used to predic
28 rrently established diagnostic modalities of dobutamine stress echocardiography (DSE) and rest-redist
29  underwent pre-randomization treadmill CPET, dobutamine stress echocardiography (DSE) and symptom ass
30 bnormal blood pressure (BP) responses during dobutamine stress echocardiography (DSE) are associated
31 vascularization techniques were studied with dobutamine stress echocardiography (DSE) before TMLR.
32 his study evaluated the incremental value of dobutamine stress echocardiography (DSE) for assessment
33 asibility, safety and diagnostic accuracy of dobutamine stress echocardiography (DSE) for evaluating
34 of this project was to assess the utility of dobutamine stress echocardiography (DSE) for evaluation
35  sought to determine the prognostic value of dobutamine stress echocardiography (DSE) for predicting
36 on analysis (WMA) during submaximal and peak dobutamine stress echocardiography (DSE) for the diagnos
37 rovement and subsequent deterioration during dobutamine stress echocardiography (DSE) has been increa
38                                   MCR during dobutamine stress echocardiography (DSE) identifies viab
39 ermine the prognostic significance of serial dobutamine stress echocardiography (DSE) in new heart tr
40 ative predictive value (NPV) of preoperative dobutamine stress echocardiography (DSE) in patients who
41 The study sought to determine the utility of dobutamine stress echocardiography (DSE) in predicting c
42                        To assess the role of dobutamine stress echocardiography (DSE) in these patien
43 hypothesis that the abnormalities induced by dobutamine stress echocardiography (DSE) may be of progn
44 mal myocardial perfusion scintigraphy (MPS), dobutamine stress echocardiography (DSE) or coronary ang
45 ardiography (TAPSE) protocol with a standard dobutamine stress echocardiography (DSE) protocol.
46                                      Because dobutamine stress echocardiography (DSE) provides assess
47 ficacy, the role of noninvasive imaging with dobutamine stress echocardiography (DSE) remains unclear
48 ents with end-stage liver disease undergoing dobutamine stress echocardiography (DSE) were evaluated
49 eline positron emission tomography (PET) and dobutamine stress echocardiography (DSE) were performed
50 th 1,012 patients who underwent conventional dobutamine stress echocardiography (DSE) without contras
51 improvement in myocardial contraction during dobutamine stress echocardiography (DSE), particularly a
52                       286 patients underwent dobutamine stress echocardiography during the study peri
53               Canine studies have shown that dobutamine stress echocardiography end points will occur
54 sis severity was assessed by a core lab with dobutamine stress echocardiography, followed by a multid
55 diography (RTCE) improves the sensitivity of dobutamine stress echocardiography for detecting coronar
56 s; 53% men) underwent outpatient exercise or dobutamine stress echocardiography for known or suspecte
57 her beta-blockade affects the sensitivity of dobutamine stress echocardiography for the diagnosis of
58                                              Dobutamine stress echocardiography has been the cornerst
59                                Increasingly, dobutamine stress echocardiography has been used for det
60                                     Although dobutamine stress echocardiography has improved sensitiv
61                                              Dobutamine stress echocardiography identified 60% of pat
62 nce on the overall diagnostic sensitivity of dobutamine stress echocardiography in our study cohort.
63                    To determine the value of dobutamine stress echocardiography in predicting cardiac
64 o assess the long-term prognostic utility of dobutamine stress echocardiography in predicting fatal a
65 e of MP and wall motion (WM) analysis during dobutamine stress echocardiography in predicting the out
66 formed rapidly and shows good agreement with dobutamine stress echocardiography in the induction of m
67 ographic features, including ischemia during dobutamine stress echocardiography, in predicting postop
68                                              Dobutamine stress echocardiography increased mean gradie
69                                              Dobutamine stress echocardiography is a useful tool for
70                                              Dobutamine stress echocardiography is a validated tool f
71                                              Dobutamine stress echocardiography is an alternative met
72                  Real-time three-dimensional dobutamine stress echocardiography is feasible and sensi
73        Despite these known pharmacodynamics, dobutamine stress echocardiography is routinely performe
74                                              Dobutamine stress echocardiography is widely accepted as
75                                              Dobutamine stress echocardiography is widely used to tes
76 Hence, measurement of GLS at rest and during dobutamine stress echocardiography may be helpful to enh
77                   Stress GLS measured during dobutamine stress echocardiography may provide increment
78                            Data suggest that dobutamine stress echocardiography may underestimate via
79                                              Dobutamine stress echocardiography, myocardial perfusion
80 tudinal strain (GLS) measured at rest and at dobutamine stress echocardiography on the outcome of pat
81 was obtained from 860 patients who underwent dobutamine stress echocardiography over a 2-year period.
82           The degree of ischemia assessed by dobutamine stress echocardiography predicts the placebo-
83 ardial contractile reserve, as determined by dobutamine stress echocardiography, predicts improvement
84 her non-invasive imaging techniques, such as dobutamine stress echocardiography, radionuclide scintig
85                                              Dobutamine stress echocardiography reliably detects mult
86                                              Dobutamine stress echocardiography results in a decrease
87 ons with more established techniques such as dobutamine stress echocardiography, single photon emissi
88 aortic stenosis used as controls) undergoing dobutamine stress echocardiography to assess FR and card
89          In total, 314 individuals underwent dobutamine stress echocardiography to detect or exclude
90 sured by speckle tracking at rest and during dobutamine stress echocardiography to document the exten
91 n gradient <40 mm Hg) who underwent low-dose dobutamine stress echocardiography to identify the AS se
92 tively studied 788 patients with RTCE during dobutamine stress echocardiography using intravenous com
93                                              Dobutamine stress echocardiography was abnormal in 10 of
94                   GLS <|10|% measured during dobutamine stress echocardiography was also independentl
95                       A standard protocol of dobutamine stress echocardiography was first performed.
96                                              Dobutamine stress echocardiography was normal in 54 of t
97                                              Dobutamine stress echocardiography was performed in 1,17
98                                              Dobutamine stress echocardiography was performed in 165
99 egments of the original stenosis zone during dobutamine stress echocardiography was significantly low
100                                              Dobutamine stress echocardiography was used in 30 patien
101                    Stress FR during low-dose dobutamine stress echocardiography was useful for the de
102 ography examinations of patients with normal dobutamine stress echocardiography were collected and un
103 contrast agent were given at rest and during dobutamine stress echocardiography when a single coronar
104                                              Dobutamine stress echocardiography with semiquantitative
105 ents with type 2 diabetes mellitus underwent dobutamine stress echocardiography with tissue Doppler i
106                                              Dobutamine stress echocardiography with use of the wall-

 
Page Top